脑梗死相关诊断性生物标记物研究进展

doi:10.3969/j.issn.1673-5765.2017.12.021

摘要/Abstract

摘要：

在目前临床实践中，卒中的诊断主要依靠临床医师对症状、体征的判断及影像学检查，但是许多疾病如偏头痛、痫性发作等可能与卒中有类似的临床表现，影像学客观检查也有一定的局限性。随着科学技术的不断进步，越来越多与脑梗死相关的诊断性生物标记物被发现，特别是新生蛋白质组及miRNA家族生物标记物的研究，对临床脑梗死的诊断有指导意义。

文章导读： 总结脑梗死相关诊断性生物标记物，特别是新生蛋白质组及miRNA家族对临床的指导意义。

关键词: 脑梗死; 生物标记物; 早期诊断; 蛋白质组; miRNA

Abstract:

In current clinical practice, diagnosis of stroke mainly depends on the physical examination of symptoms and signs as well as imaging examinations. However, many diseases such as migraine, epilepsy may have similar symptoms with stroke, and imaging examination also has certain degree of limitations. With the development of science and technology, more and more diagnostic biomarkers related to cerebral infarction are found, especially the study on nascent proteomics and miRNA family has guiding significance in the diagnosis of cerebral infarction.

Key words: Cerebral infarction; Biomarker; Early diagnosis; Proteomics; miRNA

高硕君，张祥建，张培培. 脑梗死相关诊断性生物标记物研究进展[J]. 中国卒中杂志, 2017, 12(12): 1154-1157.

GAO Shuo-Jun,ZHANG Xiang-Jian, ZHANG Pei-Pei. Research Progress of Diagnostic Biomarkers Related to Cerebral Infarction[J]. Chinese Journal of Stroke, 2017, 12(12): 1154-1157.

参考文献

[1] HAND P J，KWAN J，LINDLEY R I，et al.

Distinguishing between stroke and mimic at the

bedside：the brain attack study[J]. Stroke，2006，37

（3）：769-775.

[2] CHALELA J A，KIDWELL C S，NENTWICH

L M，et al. Magnetic resonance imaging and

computed tomography in emergency assessment of

patients with suspected acute stroke：a prospective

comparison[J]. Lancet，2007，369（9558）：293-298.

[3] FOERCH C，MONTANER J，FURIE K L，et

al. Invited article：searching for oracles? Blood

biomarkers in acute stroke[J]. Neurology，2009，73

（5）：393-399.

[4] LIU M，TANG L，LIU X，et al. An evidencebased

review of related metabolites and metabolic

network research on cerebral ischemia[J/OL].

Oxid Med Cell Longev，2016，2016：9162074.

DOI：10.1155/2016/9162074. http://dx.doi.

org/10.1155/2016/9162074.

[5] APWEILER R，ASLANIDIS C，DEUFEL T，et al.

Approaching clinical proteomics：current state and

future fields of application in fluid proteomics[J].

ClinChemLab Med，2009，47（6）：724-744.

[6] DAMBINOVA S A，KHOUNTEEV G A，

IZYKENOVA G A，et al. Blood test detecting

autoantibodies to N-methyl-D-aspartate

neuroreceptors for evaluation of patients with

transient ischemic attack and stroke[J]. Clin Chem，

2003，49（10）：1752-1762.

[7] DAMBINOVA S A，BETTERMANN K，GLYNN

T，et al. Diagnostic potential of the NMDA receptor

peptide assay for acute ischemic stroke[J/OL]. Plos

One，2012，7（7）：e42362. DOI：10.1371/journal.

pone.0042362. https://doi.org/10.1371/journal.

pone.0042362.

[8] MAESTRINI I，DUCROQUET A，MOULIN S，et

al. Blood biomarkers in the early stage of cerebral

ischemia[J]. Rev Neurol（Paris），2016，172（3）：

198-219.

[9] MONTANER J，MENDIOROZ M，DELGADO

P，et al. Differentiating ischemic from hemorrhagic

stroke using plasma biomarkers：the S100B/RAGE

pathway[J]. J Proteomics，2012，75（15）：4758-4765.

[10] KIM M S，PINTO S M，GETNET D，et al. A draft

map of the human proteome[J]. Nature，2014，509

（7502）：575-581.

[11] SHARMA R，GOWDA H，CHAVAN S，et al.

Proteomic signature of endothelial dysfunction

identified in the serum of acute ischemic stroke

patients by the iTRAQ-based LC-MS approach[J]. J

Proteome Res，2015，14（6）：2466-2479.

[12] ZHOU A. Proteomics in stroke research：potentials

of the nascent proteomics[J]. J Investig Med，2016，

64（8）：1236-1240.

[13] ZHOU A，SIMON R P，DAVID L. Nascent

proteomes of ischemic-injured and ischemic-tolerant

neuronal cells[J]. Int J Comput Biol Drug Des，2011，

4（1）：40-55.

[14] BIAN F，SIMON R P，LI Y，et al. Nascent

proteomes in peripheral blood mononuclear cells as

a novel source for biomarker discovery in human

stroke[J]. Stroke，2014，45（4）：1177-1179.

[15] MARTINEZ B，PEPLOW P V. Blood microRNAs

as potential diagnostic and prognostic markers in

cerebral ischemic injury[J]. Neural Regen Res，2016，

11（9）：1375-1378.

[16] ASANO S，CHANTLER P D，BARR T L. Gene

expression profiling in stroke：relevance of bloodbrain

interaction[J]. Curr Opin Pharmacol，2016，26：

80-86.

[17] YANG Z B，LI T B，ZHANG Z，et al. The

diagnostic value of circulating brain-specific

micrornas for ischemic stroke[J]. Intern Med，2016，

55（10）：1279-1286.

[18] SEPRAMANIAM S，TAN J R，TAN K S，et al.

Circulating microRNAs as biomarkers of acute

stroke[J]. Int J Mol Sci，2014，15（1）：1418-1432.

[19] NICHOLSON J K，CONNELLY J，LINDON J C，

et al. Metabonomics：a platform for studying drug

toxicity and gene function[J]. Nat Rev Drug Discov，

2002，1（2）：153-161.